| Log in
Pharmaceuticals Photo Credit: Shah Junaid/VCCircle

Cipla invests $3M more in Chase Pharmaceuticals

16 March, 2016

Drugmaker Cipla Ltd said on Wednesday unit Cipla UK has invested $3 million (Rs 20 crore) more in Chase Pharmaceuticals Corp as part of a previous deal.

Cipla UK’s total investment in US-based Chase Pharmaceuticals has now risen to $5.12 million for a 16.7 per cent stake, the Indian company said in a stock-exchange filing. 

In May 2014, Cipla agreed to invest $1.5 million for a 14.6 per cent stake in Chase Pharmaceuticals. At the time, Cipla said it would make an additional $4.5 million investment when the US firm achieves certain milestones.

Chase Pharmaceuticals is a clinical-stage biopharmaceutical company that is developing improved treatments for neurodegenerative disorders including Alzheimer’s disease.

Generic drugmaker Cipla has been aggressively growing its footprint internationally through acquisitions.

Last September, Cipla agreed to acquire two US companies–InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc–for around $550 million. It had also decided to acquire a 51 per cent stake in Uganda-based Quality Chemicals Ltd for $30 million.

In January, it expanded the role of promoter group scion Samina Vaziralli to include mergers and acquisitions and named Umang Vohra its global chief operating officer.


Leave Your Comment
Cipla generates four-fold returns from Chase Pharma stake sale

Cipla generates four-fold returns from Chase Pharma stake sale

Joseph Rai 1 year ago
Drugmaker Cipla Ltd has sold its entire stake in the US-based Chase...
Cipla unit exits Yemeni drugmaker Al Jabal

Cipla unit exits Yemeni drugmaker Al Jabal

Keshav Sunkara 6 months ago
Saba Investment Ltd, the Dubai-based subsidiary of pharma major Cipla Ltd, has...
Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M

Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M

Lohit Jagwani 3 years ago
Mumbai-based drugmaker Cipla Ltd is acquiring 51 per cent stake in a UAE-based...
No Comments

Cipla invests $3M more in Chase Pharmaceuticals

Powered by WordPress.com VIP